Abstract
Background: Bortezomib
Disclosures
Corso:Janssen-Cilag: Honoraria.
Author notes
*
Asterisk with author names denotes non-ASH members.
© 2016 by The American Society of Hematology
2016
Advertisement intended for health care professionals
Silvia Mangiacavalli, Federica Cocito, Virginia Valeria Ferretti, Claudio Salvatore Cartia, Maya Ganzetti, Mario Cazzola, Alessandro Corso; Impact of Switching from Intravenous to Subcutaneous Bortezomib in Real Life. Overlapping Toxicity and Efficacy in All Settings of Myeloma Patients Balancing Schedule and Way of Bortezomib Adminisration. Blood 2016; 128 (22): 5695. doi: https://doi.org/10.1182/blood.V128.22.5695.5695
Download citation file:
Background: Bortezomib
Corso:Janssen-Cilag: Honoraria.
Asterisk with author names denotes non-ASH members.
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal